Skip to main content

Table 1 Characteristics of patients and donors

From: Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China

Characteristic

HLA-matched HSCT

Haploidentical HSCT

P

(n = 35)

(n = 47)

Age, years, median (range)

35(5–52)

35(8–50)

0.679

Males/females, n

22/13

24/23

0.287

WBC count at diagnose × 109, median (range)

45.0(1.4–199.2)

36.3 (1.6–274.4)

0.147

CNS involvement

   

Yes/no

3/32

6/41

0.548

Disease status at transplantation

   

CR1

26

37

0.584

>CR1

9

10

 

BCR-ABL at transplantation

   

Negative/positive

28/7

37/10

0.888

Average mos. from diagnosis to transplant (range)

9.0(3–47)

7.0(2–19)

0.104

Cycles of prior chemotherapy (range)

5.3(2–22)

4.6(2–13)

0.411

ABO match, no. (%)

  

0.224

Matched

12

27

 

Minor mismatched

8

7

 

Major mismatched

11

9

 

Major and minor mismatched

4

4

 

Donor-recipient sex match

  

0.323

Male-male

10

16

 

Male-female

9

18

 

Female-male

12

8

 

Female-female

4

5

Â